Literature DB >> 10228060

Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.

H Jenson1, K McIntosh, J Pitt, S Husak, M Tan, Y Bryson, K Easley, W Shearer.   

Abstract

The natural history of Epstein-Barr virus (EBV) infection in 556 infants born to 517 human immunodeficiency virus (HIV) type 1-infected mothers was studied in a prospective, multicenter, cohort study. HIV-1-infected children had a cumulative EBV infection rate similar to HIV-1-uninfected children at age 3 years (77.8% vs. 84. 9%) but had more frequent oropharyngeal EBV shedding (50.4% vs. 28. 2%; P<.001). The probability of shedding decreased with longer time from EBV seroconversion and was similar to that of HIV-1-uninfected children 3 years after seroconversion. HIV-1-infected children identified as rapid progressors shed EBV more frequently than nonrapid progressors (69.4% vs.41.0%; P=.01). HIV-1-infected children with EBV infection had higher mean CD8 cell counts. EBV infection did not have an independent effect on mean CD4 cell counts, percent CD4, IgG levels, HIV-1 RNA levels, lymphadenopathy, hepatomegaly, or splenomegaly. Early EBV infection is common in children born to HIV-1-infected mothers. Children with rapidly progressive HIV-1 disease have more frequent EBV shedding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228060      PMCID: PMC4360073          DOI: 10.1086/314764

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Prevalence, incidence and persistence of EB virus antibody in young adults.

Authors:  J C Niederman; A S Evans; L Subrahmanyan; R W McCollum
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

2.  Seroepidemiologic studies of infectious mononucleosis with EB virus.

Authors:  A S Evans; J C Niederman; R W McCollum
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

3.  Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.

Authors:  J J Oudejans; M Jiwa; A J van den Brule; F A Grässer; A Horstman; W Vos; P M Kluin; P van der Valk; J M Walboomers; C J Meijer
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.

Authors:  B E Tomkinson; R Maziarz; J L Sullivan
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

5.  Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People's Republic of China.

Authors:  P S Wang; A S Evans
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

6.  Increasing incidence of cancers associated with the human immunodeficiency virus epidemic.

Authors:  C S Rabkin; R J Biggar; J W Horm
Journal:  Int J Cancer       Date:  1991-03-12       Impact factor: 7.396

7.  Persistent productive HIV infection in EBV-transformed B lymphocytes.

Authors:  V Tozzi; S Britton; A Ehrnst; R Lenkei; O Strannegård
Journal:  J Med Virol       Date:  1989-01       Impact factor: 2.327

8.  Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasma gondii.

Authors:  K Hunter; S Stagno; E Capps; R J Smith
Journal:  Am J Obstet Gynecol       Date:  1983-02-01       Impact factor: 8.661

9.  Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. The European Collaborative Study.

Authors: 
Journal:  Pediatr Infect Dis J       Date:  1992-12       Impact factor: 2.129

10.  Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.

Authors:  S M Astrin; J Laurence
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

View more
  12 in total

1.  Results of a quality assurance program for detection of cytomegalovirus infection in the pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus infection study.

Authors:  G J Demmler; A Istas; K A Easley; A Kovacs
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Authors:  Erwan Piriou; Amolo S Asito; Peter O Sumba; Nancy Fiore; Jaap M Middeldorp; Ann M Moormann; Robert Ploutz-Snyder; Rosemary Rochford
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

3.  Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.

Authors:  T L Miller; K A Easley; W Zhang; E J Orav; D M Bier; E Luder; A Ting; W T Shearer; J H Vargas; S E Lipshultz
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

4.  Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group.

Authors:  W T Shearer; K A Easley; J Goldfarb; H M Rosenblatt; H B Jenson; A Kovacs; K McIntosh
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

5.  Evaluation of immune survival factors in pediatric HIV-1 infection.

Authors:  W T Shearer; K A Easley; J Goldfarb; H B Jenson; H M Rosenblatt; A Kovacs; K McIntosh
Journal:  Ann N Y Acad Sci       Date:  2000-11       Impact factor: 5.691

6.  Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.

Authors:  Jennifer A Slyker; Corey Casper; Kenneth Tapia; Barbra Richardson; Lisa Bunts; Meei-Li Huang; Elizabeth Maleche-Obimbo; Ruth Nduati; Grace John-Stewart
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

7.  Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy.

Authors:  Hal B Jenson; Charles J Gauntt; Kirk A Easley; Jane Pitt; Steven E Lipshultz; Kenneth McIntosh; William T Shearer
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

8.  A large-scale seroprevalence of Epstein-Barr virus in Taiwan.

Authors:  Chao-Yu Chen; Kuan-Ying A Huang; Jen-Hsiang Shen; Kuo-Chien Tsao; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

9.  Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.

Authors:  Violet Kayamba; Mwaka Monze; Akwi Wasi Asombang; Kanekwa Zyambo; Paul Kelly
Journal:  Pan Afr Med J       Date:  2016-02-18

10.  Molecular profiling of gastric cancer in a population with high HIV prevalence reveals a shift to MLH1 loss but not the EBV subtype.

Authors:  Violet Kayamba; Julia Butt; Tim Waterboer; Ellen Besa; Naheed Choudhry; Anglin Hamasuku; Peter Julius; Douglas C Heimburger; Masharip Atadzhanov; Paul Kelly
Journal:  Cancer Med       Date:  2020-03-24       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.